Circulating Tumor DNA as a Prognostic Determinant in Small Cell Lung Cancer Patients Receiving Atezo...
Circulating Tumor DNA as a Prognostic Determinant in Small Cell Lung Cancer Patients Receiving Atezolizumab
About this item
Full title
Author / Creator
Herbreteau, Guillaume , Langlais, Alexandra , Greillier, Laurent , Audigier-Valette, Clarisse , Uwer, Lionel , Hureaux, José , Moro-Sibilot, Denis , Guisier, Florian , Carmier, Delphine , Madelaine, Jeannick , Otto, Josiane , Souquet, Pierre-Jean , Gounant, Valérie , Merle, Patrick , Molinier, Olivier , Renault, Aldo , Rabeau, Audrey , Morin, Franck , Denis, Marc G and Pujol, Jean-Louis
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
The IFCT-1603 trial evaluated atezolizumab in small cell lung cancer (SCLC). The purpose of the present study was to determine whether circulating tumor DNA (ctDNA), prospectively collected at treatment initiation, was associated with the prognosis of SCLC, and whether it identified patients who benefited from atezolizumab.
68 patients were incl...
Alternative Titles
Full title
Circulating Tumor DNA as a Prognostic Determinant in Small Cell Lung Cancer Patients Receiving Atezolizumab
Authors, Artists and Contributors
Author / Creator
Langlais, Alexandra
Greillier, Laurent
Audigier-Valette, Clarisse
Uwer, Lionel
Hureaux, José
Moro-Sibilot, Denis
Guisier, Florian
Carmier, Delphine
Madelaine, Jeannick
Otto, Josiane
Souquet, Pierre-Jean
Gounant, Valérie
Merle, Patrick
Molinier, Olivier
Renault, Aldo
Rabeau, Audrey
Morin, Franck
Denis, Marc G
Pujol, Jean-Louis
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7760916
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7760916
Other Identifiers
ISSN
2077-0383
E-ISSN
2077-0383
DOI
10.3390/jcm9123861
